Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
- Conditions
- Cataract
- Interventions
- Device: TECNIS Odyssey IOL
- Registration Number
- NCT06550375
- Lead Sponsor
- Mann Eye Institute
- Brief Summary
This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
• Patients aged 50 years and older who underwent bilateral cataract surgery with Odyssey IOL implantation.
- Significant ocular comorbidities (e.g., macular degeneration, glaucoma).
- < 2 weeks post YAG capsulotomy.
- Best corrected distance visual acuity worse than 20/25.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description TECNIS Odyssey IOL TECNIS Odyssey IOL -
- Primary Outcome Measures
Name Time Method Visual Acuity at Near (40cm) logMAR 3 months postoperative Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
Visual Acuity at Near (33cm) logMAR 3 months postoperative Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
Visual Acuity at Distance (6m) logMAR 3 months postoperative Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
Visual Acuity at Intermediate (66cm) logMAR 3 months postoperative Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
- Secondary Outcome Measures
Name Time Method Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) Questionniare 3 months postoperative The AIOLIS has 37 questions about symptoms, perceptions of general vision, and frequency of wearing glasses or contact lenses. Lower scores for the symptom questions indicate lower frequency and both of visual disturbances.
Trial Locations
- Locations (1)
Mann Eye Institute
🇺🇸Houston, Texas, United States